铜与动脉样硬化和治疗策略的联系
Jiawei Li1, Lin Yi2,3, Lingna Zhang1
1School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu Province, China.
Journal of cardiovascular translational research
|October 6, 2025
概括
铜不平衡与动脉样硬化 (AS) 相关,这是一种主要的心血管疾病. 了解铜代谢,稳态和细胞死亡,为AS提供了新的预防和治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 矿物质的新陈代谢.
- 病理生理学 病理生理学
背景情况:
- 动脉样硬化 (AS) 是一种慢性炎症性动脉疾病,导致全球显著的发病率和死亡率.
- 铜对心血管健康至关重要,但其平衡不平衡与AS病变产生有关.
- 铜在AS中的复杂作用是一个新兴的研究领域.
研究的目的:
- 要总结铜离子和动脉样硬化 (AS) 之间的复杂关系.
- 阐明铜代谢,平衡和铜诱导的细胞死亡在AS中的作用.
- 探索针对AS预防和治疗的铜失调的新型治疗策略.
主要方法:
- 文献综述和现有铜和动脉样硬化研究的综合.
- 对研究铜代谢和恒温的研究进行分析.
- 对心血管疾病中与铜相关的细胞死亡机制的研究进行了审查.
主要成果:
- 铜平衡中断是AS发展和进展的关键因素.
- 铜代谢,恒温和铜死亡途径在AS中显著改变.
- 有证据表明,铜的失调有助于AS的炎症过程.
结论:
- 准铜代谢和稳态,为AS提供了有前途的治疗途径.
- 了解铜诱导的细胞死亡机制可能会揭示新的治疗点.
- 调节铜平衡为AS预防和管理提供了一个新的视角.
更多相关视频
相关概念视频
Atherosclerosis III: Management
290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Atherosclerosis IV: Nursing Management
337
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
337
Coronary Artery Disease IV: Preventive Measures
563
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
563
Coronary Artery Disease I: Introduction
843
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
843
Angina IV: Management
213
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
213
Coronary Artery Disease V: Interprofessional Care
202
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
202


